U.S. And Europe Taking Steps To Advance API Quality Regulations
Executive Summary
GMP inspection clearance of an active pharmaceutical ingredient (API) supplier by the European Union or its member states will support, but not in itself satisfy, the GMP oversight responsibility placed on the drug manufacturer under the new EU requirements